Healthcare Innovation

European Commission Approves MSD’s ENFLONSIA™ for Prevention of RSV Lower Respiratory Tract Disease in Infants

Clinical FeaturesClinical LeadershipHealthHealth PolicyHealthcare InnovationHealthy IrelandHospital NewsLatest NewsPaediatricsPolicy & RegulationPublic HealthResearch & InnovationRespiratory

MSD has announced European Commission approval for ENFLONSIA™ (clesrovimab) for the prevention of RSV lower respiratory tract disease in newborns and infants during their first RSV season.

Read more